SecBot SecBot
SECBOTREPLAY Home › Report › TWST

TWST · A cluster of insider sales at Twist Bioscience totaling $4.39M occurred…

Twist Bioscience Corp · CLUSTER filed Aug 11, 2026 at 16:05 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 11, 2026 at 16:05 ET

A cluster of insider sales at Twist Bioscience totaling $4.39M occurred within 9 days of a strong Q3 2026 earnings beat and raised guidance. The sales include CEO Emily Leproust ($435K), President/COO Patrick Finn ($246K), and Director Robert Chess ($2.04M, following option exercises). While the earnings report was bullish (revenue +23% YoY, guidance raised), the insider selling cluster, particularly the CEO's open-market sale, introduces a cautionary signal that partially offsets the positive fundamental momentum. The total sale value represents ~0.05% of the $8.2B market cap, which is below the 0.1% materiality threshold, suggesting these are routine liquidity-driven sales rather than informed bearish bets, especially given the stock's 94% analyst bullish consensus and strong historical performance.

  • Insider cluster of 6 sales totaling $4.39M over 7 days (Aug 1-7, 2026)
  • CEO Emily Leproust sold $435K in open-market shares on Aug 3
  • Director Robert Chess sold $2.04M on Aug 7 after exercising options at $11.89
  • Sales occurred 9 days after Twist reported Q3 FY2026 revenue of $118.4M (+23% YoY, beat consensus) and raised FY guidance to $456-457M

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access